Stock 688276 CHANGCHUN BCHT BIOTECHNOLOGY CO.
Add to a list
To use this feature you must be a member
Log inSign up

Company Changchun BCHT Biotechnology Co.

Equities

688276

CNE100005XY6

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 25/06/2024 am IST 		5-day change 1st Jan Change
28.54 CNY +0.71% Intraday chart for Changchun BCHT Biotechnology Co. -8.26% -47.93%
24/04 Chinese Drug Regulator Accepts BCHT Biotechnology's Marketing Application for Influenza Nasal Spray Vaccine MT
19/04 Changchun BCHT Biotechnology Co. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Changchun BCHT Biotechnology Co is a China-based innovative biomedical company mainly dedicated to the prevention and treatment of infectious diseases. The Company is mainly engaged in the research and development, production and sales of human vaccines. The Company has three approved vaccine products: varicella vaccine, rabies vaccine and freeze-dried nasal spray flu vaccine. The Company also has other vaccines under development and fully human monoclonal antibody under development for the prevention and control of infectious diseases. The Company mainly conducts business within the domestic market.

Number of employees: 1,241

Sales per Business

CNY in Million2022Weight2023Weight Delta
Shingles Vaccine
48.4 %
- - 883 48.4 % -
Chickenpox Vaccine
44.9 %
957 89.4 % 820 44.9 % -14.36%
Nasal Spray Flu Vaccine
6.7 %
114 10.6 % 122 6.7 % +6.85%
Other Business
0.0 %
0 0.0 % 0 0.0 % +193.12%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
98.1 %
1,051 98.1 % 1,789 98.1 % +70.22%
Abroad
1.9 %
20 1.9 % 35 1.9 % +74.43%

Managers

Managers TitleAgeSince
Wei Kong CEO
 Chief Executive Officer 59 01/04/01
Zhao Feng Meng DFI
 Director of Finance/CFO 60 01/19/01
Da Qiang Feng CHM
 Chairman 58 01/04/01
Chang Lin Zhu CTO
 Chief Tech/Sci/R&D Officer 56 01/04/01
Chun Lai Jiang BRD
 Director/Board Member 51 01/09/01
Xiu Feng Li BRD
 Director/Board Member 55 01/04/01
Xue Lian Tong IRC
 Investor Relations Contact 34 01/17/01
Zhe Zhang IRO
 Public Communications Contact 49 01/04/01

Members of the board

Members of the board TitleAgeSince
Xiu Feng Li BRD
 Director/Board Member 55 01/04/01
Xing Gong Zhu BRD
 Director/Board Member 57 03/21/03
De Shen Zhang BRD
 Director/Board Member 60 21/19/21
Ji Ma CHM
 Chairman 59 09/21/09
Yun Tao Jiang BRD
 Director/Board Member 50 01/18/01
Wei Kong CEO
 Chief Executive Officer 59 01/04/01
Chun Lai Jiang BRD
 Director/Board Member 51 01/09/01
Bai Nian Fu BRD
 Director/Board Member 68 01/20/01
Da Qiang Feng CHM
 Chairman 58 01/04/01
Yang Yang BRD
 Director/Board Member 39 01/10/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 413,657,598 89,155,673 ( 21.55 %) 0 21.55 %

Shareholders

NameEquities%Valuation
Wei Kong
43.01 %
104,448,497 43.01 % 490 M ¥
Xue Ning Wei
8.629 %
20,954,688 8.629 % 98 M ¥
Xiao Hui Chen
2.466 %
5,987,472 2.466 % 28 M ¥
China Merchants Fund Management Co., Ltd.
2.319 %
5,631,086 2.319 % 26 M ¥
Shang Shu Hu
2.100 %
5,100,000 2.100 % 24 M ¥
Sheng Yu
1.705 %
4,140,000 1.705 % 19 M ¥
National Social Security Fund Portfolio 118
1.701 %
4,130,787 1.701 % 19 M ¥
Hong Wang
1.343 %
3,260,095 1.343 % 15 M ¥
City of Changchun
1.192 %
2,895,124 1.192 % 14 M ¥
Penghua Fund Management Co., Ltd.
1.043 %
2,533,119 1.043 % 12 M ¥

Company contact information

Changchun BCHT Biotechnology Co.

138, Zhuoyue Street Chaoyang District

130103, Changchun

+86 431 8187 1520

http://www.bchtpharm.com
address Changchun BCHT Biotechnology Co.(688276)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Sales per region

Ratings for Changchun BCHT Biotechnology Co.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
28.54 CNY
Average target price
54.56 CNY
Spread / Average Target
+91.19%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-47.93% 161.5Cr
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+15.93% 894.91Cr
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-24.00% 431.05Cr
YUHAN CORPORATION Stock Yuhan Corporation
+13.37% 421Cr
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+31.17% 410.48Cr
INDIVIOR PLC Stock Indivior PLC
+6.41% 220.57Cr
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-34.04% 196.02Cr
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+7.56% 194.75Cr
VELOXIS PHARMACEUTICALS A/S Stock Veloxis Pharmaceuticals A/S
-0.50% 164.41Cr
SUPERNUS PHARMACEUTICALS, INC. Stock Supernus Pharmaceuticals, Inc.
-8.40% 147.94Cr
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 688276 Stock
  4. Company Changchun BCHT Biotechnology Co.